Back
Johnson & Johnson Vs. Pfizer Industry Stock Comparison
Sell
32
JNJ
Johnson & Johnson
Last Price:
154.80
Seasonality Move:
2.05%
Sell
37
PFE
Pfizer
Last Price:
28.50
Seasonality Move:
1.2%
Sell
32
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $154.64. The Score for JNJ is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $28.64. The Score for PFE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $154.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
PFE Stock Price Chart
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 63.68 | Buy |
| Chaikin Money Flow: | 3751341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (146.21 - 151.59) | Buy |
| Bollinger Bands (100): | (150.78 - 160.88) | Sell |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 64.11 | Buy |
| Chaikin Money Flow: | -8983346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.74 - 28.3) | Buy |
| Bollinger Bands (100): | (26.47 - 28.53) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 151.61 | Buy |
| 20-day SMA: | 149.61 | Buy |
| 50-day SMA: | 152.33 | Buy |
| 200-day SMA: | 156.92 | Sell |
| 8-day EMA: | 152.13 | Buy |
| 20-day EMA: | 150.74 | Buy |
| 50-day EMA: | 152 | Buy |
| 200-day EMA: | 156.42 | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.46 | Buy |
| 20-day SMA: | 27.35 | Buy |
| 50-day SMA: | 27.19 | Buy |
| 200-day SMA: | 29.85 | Sell |
| 8-day EMA: | 28.4 | Buy |
| 20-day EMA: | 27.72 | Buy |
| 50-day EMA: | 27.37 | Buy |
| 200-day EMA: | 30.22 | Sell |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.13 per share, an increase this year of $0.74 per share, and an increase next year of $0.31 per share.
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.81 per share, and an increase next year of $0.39 per share.
Johnson & Johnson Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||